No photo of Roger Stupp

View Scopus Profile

Roger Stupp

  • 38451 Citations
1990 …2023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Education/Academic qualification

MD, University of Zurich

… → 1987

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
temozolomide Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Glioma Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2017 2023

SPORE for Translational Approaches to Brain Cancer

Ahmed, A. U., Balyasnikova, I. V., Bartom, E. T., Brat, D. J., Chandler, J. P., Cheng, S., Horbinski, C. M., Hu, B., James, C. D., Kumthekar, P. U., Leikin, R. G., Lesniak, M. S., Liu, B. P., Lukas, R. V., Mirkin, C. A., Platanias, L. C., Sachdev, S., Scholtens, D. M., Stegh, A. H., Stupp, R. & Wainwright, D. A.

National Cancer Institute

8/17/18 → 7/31/23

Project: Research project

Brain Neoplasms
Glioblastoma
Therapeutics
Neoplasms
Survival

DRUG MRZ-112 - Phast 1B, Multicenter, Open-Label Study of Marizomib Combined with Temozolomide and Radiotherapy in Ptients with Newly Diagnosed who Grade IV Malignant Glioma

Stupp, R.

Triphase Accelerator US Corp., Celgene International II Sàrl

9/25/17 → 9/25/20

Project: Research project

Research Output 1990 2019

Drug development for glioma: are we repeating the same mistakes?

Stupp, R., Jan 1 2019, In : The Lancet Oncology. 20, 1, p. 10-12 3 p.

Research output: Contribution to journal › Comment/debate

Glioma
Pharmaceutical Preparations
2 Citations (Scopus)

Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod

Lukas, R. V., Juhász, C., Wainwright, D. A., James, C. D., Kennedy, E., Stupp, R. & Lesniak, M. S., Jan 15 2019, In : Journal of Neuro-Oncology. 141, 1, p. 111-120 10 p.

Research output: Contribution to journal › Article

Indoleamine-Pyrrole 2,3,-Dioxygenase
Glioblastoma
Tryptophan
Positron-Emission Tomography
temozolomide
1 Citation (Scopus)

Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033

Dirven, L., Reijneveld, J. C., Taphoorn, M. J. B., Coens, C., El-Badawy, S. A., Tzuk-Shina, T., Bravo-Marques, J., Back, M., Stalpers, L. J. A., Stupp, R., Baumert, B. G. & Seidel, C., May 1 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 1, p. 90-100 11 p.

Research output: Contribution to journal › Article

Glioma
health
grade
cancer
Quality of Life

Improving survival in molecularly selected glioblastoma

Stupp, R., Lukas, R. V. & Hegi, M. E., Feb 16 2019, In : The Lancet. 393, 10172, p. 615-617 3 p.

Research output: Contribution to journal › Comment/debate

Glioblastoma

Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels

Hottinger, A. F., Bensaid, D., De Micheli, R., Moura, B., Mokhtari, K., Cardoso, E., Idbaih, A. & Stupp, R., Jan 1 2019, In : Annals of Oncology. 30, 1, p. 155-156 2 p.

Research output: Contribution to journal › Letter

Glioma
Pharmaceutical Preparations
Neoplasms